
Pancreatic Cancer Europe (PCE) is pleased to be part of the new Patient Representatives Advisory Board (PRAB), launched by United European Gastroenterology (UEG) on 18 October at UEG Week 2026 in Barcelona.
The board creates a dedicated platform for patient organisations to contribute to UEG’s public affairs activities and wider work to improve digestive health across Europe. It will bring together perspectives from across digestive diseases, helping ensure that patients’ experiences and priorities inform advocacy and collaboration.
The launch took place during the Digestive Health Roundtable 2026, where patient representatives, clinicians, researchers and other stakeholders explored how to strengthen patient involvement in digestive health research. Discussions covered patient-reported outcome measures, involvement throughout the research lifecycle and the development of a practical toolkit.
Through its participation, PCE will help bring the perspectives of people affected by pancreatic cancer into these discussions, working alongside fellow patient organisations to identify shared challenges and advance common priorities.
The initiative builds on the Digestive Health Roundtable 2025 and its Manifesto, which called for patients to be recognised as co-creators of digestive health policy, research and care.
Read the press release here.